Unlearn Reviews

Unlearn Description

AI advances will eliminate the need for trial and error in medical practice. Our digital twins allow for confident and rapid clinical trials. We work in neurology, immunology and metabolic disease. TwinRCTs achieve full enrollment faster because they need fewer patients in order to achieve the same power of traditional trial designs. Enrollment time in late-stage trials can be shortened. TwinRCTs increase the power of early-stage studies without adding additional patients, allowing them to observe treatment effects. Early-stage studies can be used to make confident decisions and attract participants. TwinRCTs increase the chances of participants receiving experimental treatments because they use smaller controls groups. Position clinical trials using digital twins to achieve regulatory success. Unlearn engineers the future of medicine using artificial intelligence. We create and deploy new types generative models based on patient-level data.